About us
Anumana, Inc.™ is a health technology company from nference and Mayo Clinic Platform, harnessing industry-leading AI and translational science to decode the electrocardiogram as never before – as a deep predictive tool and biomarker of disease – empowering care providers to help patients early.
Anumana algorithms have been developed, trained, and validated using clinical data from Mayo Clinic, and leverages the powerful augmented intelligence software from nference, nferX®. Anumana is developing AI-enabled ECG algorithms for real-world physician use, integrating point-of-care applications into existing workflows, thereby reducing costs, improving outcomes, and enhancing quality of life. Anumana’s AI-enabled tools can diagnose hidden conditions earlier than ever before. Anumana’s algorithms are investigational medical devices and have not yet received regulatory approval or clearance. For more information, follow Anumana on LinkedIn and Twitter.
Leadership
Murali Aravamudan
Chief Executive Officer
David McMullin
Chief Business Officer
Samir Awasthi, MD, PhD
Vice President of Clinical Research
Rakesh Barve, PhD
Vice President of Data Science and Engineering
Tyler Wagner, PhD
Vice President of Biomedical Research
Hutch Fishman
Chief Financial Officer
Advisors
Paul Friedman, MD
Chair of the Department of Cardiovascular Medicine at Mayo Clinic
Advisory Board Chair
Samuel J. Asirvatham, MD
Electrophysiologist at Mayo Clinic
Zachi Attia, PhD
Director of Artificial Intelligence in Cardiology at Mayo Clinic
Francisco Lopez-Jiminez, MD, MBA
Chair of the Division of Preventive Cardiology at Mayo Clinic
Rickey Carter, PhD
Leader, Digital Innovation Laboratory at Mayo Clinic
Partner with us!
We’re actively developing algorithms for FDA approval. Please direct partnership and media inquiries to info@anumana.net
Let's Connect